BIOL Stock Earnings: Biolase Misses EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
BIOL stock results show that Biolase missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
The post BIOL Stock Earnings: Biolase Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace